Metastatic colon cancer cell populations contain more cancer stem-like cells with a higher susceptibility to natural killer cell-mediated lysis compared with primary colon cancer cells

Oncology Letters
Ga Rim KimChi-Dug Kang

Abstract

In the present study, the soft agar clonogenicity and the susceptibility of clonogenic cancer cells to natural killer (NK) cells were compared between primary colon cancer cells (KM12C) and metastatic colon cancer cells (KM12L4a and KM12SM) to determine whether the metastatic cancer cells consisted of more cancer stem-like cells and were resistant to NK cell-mediated lysis. The majority of colon cancer cells were positive for putative cancer stem cell markers, including CD44, CD133 and EpCAM, with the exception of KM12C cells, of which only ~55% were positive for CD133. In addition, the expression levels of sex determining region Y-box 2, Nanog and octamer-binding transcription factor 4, which are essential for maintaining self-renewal, were higher in KM12L4a and KM12SM compared with that in KM12C cells. Consistently, an increased clonogenicity of KM12L4a and KM12SM compared with KM12C cells in soft agar was observed. The expression levels of NKG2D ligands, including major histocompatibility complex class I polypeptide-related sequence A/B and UL16 binding protein 2, and of death receptor 5 were significantly higher in KM12L4a and KM12SM than in KM12C cells. Furthermore, the results indicated an increased susceptibility of KM12...Continue Reading

References

Jul 29, 1977·Science·A W Hamburger, S E Salmon
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Apr 20, 2002·Clinical & Experimental Metastasis·L OliverF M Vallette
Jun 2, 2004·International Journal of Cancer. Journal International Du Cancer·Jordi CampsRosa Miró
Dec 21, 2004·Molecular Immunology·Mark J SmythYoshihiro Hayakawa
Nov 18, 2006·Cell·Gaorav P Gupta, Joan Massagué
Nov 24, 2006·Nature·Lucia Ricci-VitianiRuggero De Maria
Apr 18, 2007·Nature Reviews. Immunology·Hans-Gustaf Ljunggren, Karl-Johan Malmberg
Jun 6, 2007·Proceedings of the National Academy of Sciences of the United States of America·Piero DalerbaMichael F Clarke
Mar 5, 2008·Cancer Immunology, Immunotherapy : CII·Karl-Johan MalmbergHans-Gustaf Ljunggren
Oct 29, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roger W McGilvrayLindy G Durrant
Dec 3, 2010·The Journal of Pathology·Malcolm R AlisonLinda J Nicholson
Mar 10, 2011·Nature Medicine·Hans Clevers
Mar 26, 2011·Science·Christine L Chaffer, Robert A Weinberg
Jul 19, 2012·Molecular Cancer Therapeutics·Kristi ElkinsAndrew G Polson
Oct 12, 2012·Frontiers in Immunology·Lola Fernández-MessinaMar Valés-Gómez
Jan 10, 2013·Annual Review of Immunology·David H RauletHeiyoun Jung
Jan 25, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rossana TallericoEnnio Carbone
Mar 23, 2013·Annual Review of Immunology·Eric O LongSumati Rajagopalan
Apr 13, 2013·Cell Death and Differentiation·C J ChanL Martinet
May 4, 2013·British Journal of Pharmacology·O MicheauF Dufour
May 21, 2013·Acta Pharmacologica Sinica·Ke ChenJi-long Chen
May 31, 2013·Journal of Immunotherapy·Michael A SheardRobert C Seeger
Feb 28, 2014·World Journal of Gastroenterology : WJG·Caterina FanaliAlessandro Sgambato

❮ Previous
Next ❯

Citations

Jun 16, 2016·Scientific Reports·Jiefu JinZaver M Bhujwalla
Mar 12, 2021·Cancer Immunology, Immunotherapy : CII·Alejandra LeivasJoaquín Martínez-López

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytomtery

Software Mentioned

CellQuest
BD FACSDiva

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.